Astera Labs (NASDAQ:ALAB) Stock Price Down 3.2% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB)’s share price traded down 3.2% during trading on Wednesday . The stock traded as low as $329.40 and last traded at $330.86. 5,865,470 shares changed hands during mid-day trading, an increase of 5% from the average session volume of 5,561,926 shares. The stock had previously closed at $341.70.

Analyst Ratings Changes

Several equities analysts have commented on the company. Morgan Stanley upped their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Roth Mkm reaffirmed a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. TD Cowen upped their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Finally, Needham & Company LLC upped their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Stock Performance

The firm has a market capitalization of $56.71 billion, a P/E ratio of 223.55, a price-to-earnings-growth ratio of 4.59 and a beta of 3.95. The stock has a 50-day moving average of $222.18 and a 200 day moving average of $174.67.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 2,321,256 shares of company stock worth $480,893,146. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Glenmede Trust Co. NA lifted its stake in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the period. Verus Capital Partners LLC lifted its stake in shares of Astera Labs by 16.4% in the 1st quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after purchasing an additional 541 shares during the period. Liontrust Investment Partners LLP lifted its stake in shares of Astera Labs by 98.7% in the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock valued at $11,538,000 after purchasing an additional 52,284 shares during the period. SOA Wealth Advisors LLC. acquired a new position in shares of Astera Labs in the 1st quarter valued at $49,000. Finally, E20 Capital Ltd acquired a new position in shares of Astera Labs in the 1st quarter valued at $33,310,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.